Experience

CTI Clinical Trial and Consulting Services

• United States
• Research Services
• 700 & Above Employee

• Vice President Global Laboratory Services

  • Oct 2020 - Present

  This new role at CTI, Vice President Global Laboratory Services, leads Strategic and Operational leadership for the build, development and implementation of a global Laboratory Business Unit, including the identification of facilities, acquisition targets, and hiring resources globally, Additionally, this role is responsible for cultivating external relationships and collaborations with manufacturers, strategic partners, clients and thought leaders, Global P&L responsibilities. This new role at CTI, Vice President Global Laboratory Services, leads Strategic and Operational leadership for the build, development and implementation of a global Laboratory Business Unit, including the identification of facilities, acquisition targets, and hiring resources globally, Additionally, this role is responsible for cultivating external relationships and collaborations with manufacturers, strategic partners, clients and thought leaders, Global P&L responsibilities.



ProScan Imaging

• Medical Practices
• 100 - 200 Employee

• Executive Vice President, Managing Partner

  • Dec 2013 - Oct 2020

  Responsible for developing and managing global transformational business growth opportunities within the ProScan family of businesses. Specifically focused on their healthcare technology product and service businesses and their teleradiology offerings. Led Imaging Core Lab Business Unit (WorldCare Clinical Imaging) conversion from Academic to Commercial business model, top and bottom line growth and asset sale in 2019. Responsible for developing and managing global transformational business growth opportunities within the ProScan family of businesses. Specifically focused on their healthcare technology product and service businesses and their teleradiology offerings. Led Imaging Core Lab Business Unit (WorldCare Clinical Imaging) conversion from Academic to Commercial business model, top and bottom line growth and asset sale in 2019.



IQVIA

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Vice President, Global Late Phase Business Development

  • Nov 2011 - Nov 2013

  With a team of Real World & Late Phase Business Development Specialists, responsible for building and expanding relationships that will drive Quintiles Late Phase Interventional/Observational/ Clinical - Commercial Convergence business globally. Key liaison and business lead to Global Sales, Consulting, Commercial and Therapeutic Delivery Organizations. Built EU and Asian Late Phase Sales Teams resulting in significant business growth. Direct Reporting into Executive Committee. We doubled our business in 2012 and continued to over perform in 2013. Show less



INC Research

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• • Jan 2009 - Jan 2012

  Responsible for the development/expansion of preferred provider and strategic alliance relationships with major biopharmaceutical companies. Managed a Team of 8-12 Senior Business Development Executives Globally

• • Jan 2001 - Dec 2008

  Overall Responsibility for the global development and maintenance of key global large Pharmaceutical Accounts (Pfizer, sanofi-aventis, Merck, Bayer, J&J, etc...). The work includes strategic business development, relationship management and contract negotiation and management. Manage a team of business development executives (6 associates) focused on strategically servicing these key accounts. Secured $200 million in new business in 2007 alone. Personal sales in 2007 exceeded $88 million.



Hologic, Inc.

• United States
• Medical Equipment Manufacturing
• 700 & Above Employee

• Corporate National Accounts Manager

  • Sep 1996 - Jun 2000

  Responsible for developing a strong Corporate National Accounts Program for $120MM X-ray Digital Imaging Company. Primary focus on large and mid-size GPO’s, Hospital Networks, MCO’s, and IDN’s. Securing and Managing Corporate contracts & relationships with Columbia/HCA, AmeriNet, MHA/Medicon, Consorta, Tenet, Kaiser, Novation, VA Hospitals, UHS, AIA, as well as pharmacy segment, etc. Corporate Accounts generate 10% of overall revenues annually. Responsible for developing a strong Corporate National Accounts Program for $120MM X-ray Digital Imaging Company. Primary focus on large and mid-size GPO’s, Hospital Networks, MCO’s, and IDN’s. Securing and Managing Corporate contracts & relationships with Columbia/HCA, AmeriNet, MHA/Medicon, Consorta, Tenet, Kaiser, Novation, VA Hospitals, UHS, AIA, as well as pharmacy segment, etc. Corporate Accounts generate 10% of overall revenues annually.



Procter & Gamble

• United States
• Manufacturing
• 700 & Above Employee

• Technical Brand Manager - Drug Development

  • Oct 1987 - Sep 1996

  Responsible for Global Publication Planning of 14 Phase III studies and 16 Phase II studies (20,000 patients worldwide) through the development of publications in strategic medical journals. Collaborated with Thought Leaders in the development of pre-market launch materials, which included abstracts, posters, oral presentations, symposia & peer review publications. Responsible for coordinating an Osteoporosis Clinical Advisory Board to evaluate/assist in Risedronate product launch strategies. Co-developed and maintained Clinical databases which included data on Osteoporosis, Paget’s Disease, Hypercalcemia of Malignancy, and Multiple Myeloma. Coordinated Speaker Programs, poster sessions, and key symposia at International osteoporosis conferences. Primary contact for all Thought Leaders worldwide. Collaborated with Marketing, Sales, Professional Relations, Medical Affairs, Legal and Regulatory Affairs in the development of pre-market launch materials for Risedronate (Actonel). Show less